Isaca Updated CRISC Exam Questions and Answers by ellen

Residual risk is the risk that remains after the implementation of risk responses. An effective risk management program should aim to reduce the residual risk to a level that is acceptable by the enterprise, in alignment with its risk appetite and tolerance. The reduction of residual risk indicates that the risk responses are appropriate and effective, and that the enterprise is achieving its objectives while managing its risks. The other options are not necessarily indicative of an effective risk management program, as they may depend on other factors, such as the reporting culture, the audit scope and methodology, and the nature and source of the inherent risk. References = Risk and Information Systems Control Study Manual, 7th Edition, Chapter 1, Section 1.2.3.1, pp. 24-25.

The acquisition phase of the system development life cycle (SDLC) is the phase where the organization decides to purchase a new IT system from an external vendor or develop it internally. During this phase, the identified risks will most likely lead to architecture and design trade-offs, as the organization will have to balance the cost, quality, functionality, security, and performance of the new IT system. The organization will have to evaluate the different options and alternatives available, and select the one that best meets the business needs and the risk appetite. The other phases of the SDLC are not as likely to involve architecture and design trade-offs, as they are more focused on implementing, testing, deploying, and maintaining the new ITsystem. References = Risk and Information Systems Control Study Manual, Chapter 3: IT Risk Response, Section 3.2: IT Risk Response Options, page 133.

The greatest concern associated with the transmission of healthcare data across the internet is unencrypted data, as this exposes the data to unauthorized access, interception, modification, or disclosure, which may compromise the confidentiality, integrity, and availability of the data. Healthcare data is sensitive and personal information that may include medical records, diagnoses, treatments, prescriptions, insurance claims, and biometric data. Healthcare data is subject to various legal and regulatory requirements, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, that mandate the protection and privacy of the data. Encryption is a method of transforming the data into an unreadable format that can only be accessed or restored by authorized parties who have the decryption key. Encryption helps to prevent or reduce the risk of data breaches, identity theft, fraud, or other malicious attacks. The other options are not the greatest concerns associated with the transmission of healthcare dataacross the internet, although they may pose some challenges or issues. Lack of redundant circuits is a concern for the reliability and continuity of the data transmission, but it does notaffect the security or privacy of the data. Low bandwidth connections is a concern for the speed andefficiency of the data transmission, but it does not affect the security or privacy of the data. Data integrity is a concern for the accuracy and completeness of the data, but it does not necessarily depend on the encryption of the data. References = Risk and Information Systems Control Study Manual, Chapter 4: Risk Response, page 156.

 The first course of action for a risk practitioner when an organization plans to adopt a cloud computing strategy is to perform a controls assessment. This means evaluating the existing controls in the organization and the cloud service provider, and identifying the gaps and weaknesses that need to be addressed. A controls assessment can help to determine the level of risk exposure and the suitability of the cloud service model and provider for the organization’s needs and objectives. It can also help to establish the baseline for monitoring and reporting on the cloud service performance and compliance. References = Risk and Information Systems Control Study Manual, Chapter 5, Section 5.3.2.2, p. 242-243